TWO SIGMA INVESTMENTS, LP - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$2,061,000
-80.6%
47,700
-81.1%
0.01%
-78.0%
Q2 2015$10,646,000
+898.7%
251,925
+816.1%
0.05%
+900.0%
Q1 2015$1,066,000
-77.6%
27,500
-80.6%
0.01%
-80.8%
Q4 2014$4,769,000
-51.3%
141,653
-49.3%
0.03%
-40.9%
Q3 2014$9,784,000
+38.1%
279,391
+29.5%
0.04%
+37.5%
Q2 2014$7,087,000
+119.5%
215,685
+156.5%
0.03%
+77.8%
Q4 2013$3,228,000
-13.2%
84,100
-38.0%
0.02%
-25.0%
Q3 2013$3,720,000
-33.4%
135,732
-49.0%
0.02%
-38.5%
Q2 2013$5,589,000266,1450.04%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 1,055,000$40,491,00027.81%
DELTA PARTNERS LP 309,732$11,888,00013.39%
Black Creek Investment Management Inc. 2,457,034$94,301,00011.10%
Consonance Capital Management LP 1,252,314$48,064,0007.88%
Sloane Robinson LLP 247,700$9,507,0005.56%
GRATRY & Co LLC 205,800$7,899,0002.59%
Grandeur Peak Global Advisors, LLC 230,385$8,842,0002.36%
Mirae Asset Global Investments Co., Ltd. 1,130,882$43,403,0001.82%
Integre Asset Management, LLC 200,173$7,683,0001.74%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 90,560$3,476,0001.64%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders